Nauman Khalid is a Cardiology physician affiliated with St. Francis Medical Center. OpenAlex indexes 173 publications with 1,392 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
411 Calypso St Ste 210
Monroe, LA 712017551
Telephone
318-966-6500Provider last certified this registry record 8 Jul 2024.
Industry payments
43 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202512 payments
- ABIOMEDProgram year20259 payments
- Shockwave Medical, IncProgram year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.9%Beta blocker20.1%Metoprolol Succinate69%Carvedilol18%Metoprolol Tartrate13%Part D<11 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)12.2%Entresto100%Part D≥24 patients+ 8 more classes in this area
Blood & clotting
18.2%P2Y12 inhibitor11.2%Clopidogrel100%Part D≥35 patientsFactor Xa inhibitor7%Eliquis100%Part D≥18 patientsMetabolism & gastrointestinal
4.9%SGLT2 inhibitor3%Jardiance100%Part D<11 patientsPotassium supplement1.9%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory Support
Circulation Cardiovascular Interventions
2021 - Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study)
International Journal of Cardiology
2021 - <scp>Real‐world</scp> experience of <scp>suture‐based</scp> closure devices: Insights from the <scp>FDA</scp> Manufacturer and User Facility Device Experience
Catheterization and Cardiovascular Interventions
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Ciaburri, MD, MBA
St. Francis Medical Center
Myles Lee, MD
St. Francis Medical Center
Robert Sabo, MD
St. Francis Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”